AMR Logo.png
Transdermal Drug Delivery Systems Market to Hit $87.32 Billion by 2030: Allied Market Research
June 27, 2022 08:51 ET | Allied Market Research
Portland, OR, June 27, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global transdermal drug delivery systems market generated $52.47 billion in 2020, and is...
Sm-logo-resized.jpg.png
Digital Therapeutics Market will be worth USD 28.21 Billion in 2030 and is expected to grow at a CAGR of 21.36%.
June 21, 2022 10:50 ET | STRATEGIC MARKET RESEARCH LLP
New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The Digital Therapeutics industry showcases a high growth rate due to the increasing penetration of smartphones and other electronic...
L-Nutra Reports on First-of-Its Kind Study Showing That Fasting Nutrition Program Improves Metabolic Control and Slows Diabetic Kidney Disease in Type 2 Diabetes Patients
June 21, 2022 10:00 ET | L-Nutra, Inc.
LOS ANGELES, June 21, 2022 (GLOBE NEWSWIRE) -- L-Nutra Inc., the world's leading nutrition technology company pioneering the discovery, design, and commercialization of novel nutrition programs that...
MicrosoftTeams-image (5).png
Ultra-large Volume Wearable Injectors Market to Surpass Valuation of US$ 6.6 Bn by 2031: TMR Study
June 09, 2022 08:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 09, 2022 (GLOBE NEWSWIRE) -- The demand analysis of ultra-large volume wearable injectors reiterates the growing trend of subcutaneous routes of...
vTv Graps Logo.png
vTv Therapeutics Announces Publication in Diabetes Obesity and Metabolism of Complete Results for the Mechanistic Study Assessing Effects of TTP399 on Ketones during Acute Insulin Withdrawal in Patients with Type 1 Diabetes
June 04, 2022 11:00 ET | vTv Therapeutics Inc.
HIGH POINT, N.C., June 04, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of orally administered treatments for...
 Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Sessions of the American Diabetes Association
June 03, 2022 16:00 ET | INVENTIVA
Daix (France), Long Island City (New York, United States), June 3, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...
 Inventiva annonce la présentation d’un abstract scientifique lors de la 82nd Scientific Sessions of the American Diabetes Association
June 03, 2022 16:00 ET | INVENTIVA
Daix (France), Long Island City (New York, United States), le 3 juin 2022 – Inventiva (Euronext Paris et Nasdaq : IVA) (la « Société »), société biopharmaceutique spécialisée dans le développement de...
vTv Graps Logo.png
vTv Therapeutics Announces Investment by and Entry into Collaboration and License Agreement with affiliates of G42 Healthcare
June 01, 2022 06:54 ET | vTv Therapeutics Inc.
HIGH POINT, N.C., June 01, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $25 million investment by G42 Investments AI Holding RSC...
eyenuk_logo_redesign_2017_onecolor.png
UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service
June 01, 2022 03:05 ET | Eyenuk, Inc.
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Innovation Zed and SNAQ Collaborate to Improve Health Outcomes for People With Diabetes
May 30, 2022 01:00 ET | Innovation Zed Ltd.
DUBLIN, May 30, 2022 (GLOBE NEWSWIRE) -- Innovation Zed, an Irish MedTech R&D company, today announced the signing of a global partnership and data integration agreement for its family of...